BamSEC and AlphaSense Join Forces
Learn More

NAVIDEA BIOPHARM. DL-001

OTC: NO1A:MU    
Share price (10/14/24): $0.05    
Market cap (10/14/24): $4.604 million
Search in Documents
Key Exhibits
External Links

Credit Agreements Filter

EX-10.1
from 8-K 10 pages Loan and Securities Exchange Agreement
12/34/56
EX-10.1
from 8-K 54 pages Stock Exchange and Loan Agreement
12/34/56
EX-10.1
from 8-K 23 pages Amendment 1 to Term Loan Agreement
12/34/56
EX-10.1
from 8-K/A 115 pages Term Loan Agreement Dated as of May 8, 2015 Between Navidea Biopharmaceuticals, Inc. as Borrower, the Subsidiary Guarantors From Time to Time Party Hereto, and Capital Royalty Partners II L.P., Capital Royalty Partners II – Parallel Fund “A” L.P. and Parallel Investment Opportunities Partners II L.P. as Lenders U.S. $60,000,000
12/34/56
EX-10.1
from 8-K/A 115 pages Term Loan Agreement Dated as of May 8, 2015 Between Navidea Biopharmaceuticals, Inc. as Borrower, the Subsidiary Guarantors From Time to Time Party Hereto, and Capital Royalty Partners II L.P., Capital Royalty Partners II – Parallel Fund “A” L.P. and Parallel Investment Opportunities Partners II L.P. as Lenders U.S. $60,000,000
12/34/56
EX-10.4
from 8-K 10 pages Third Amendment to Loan Agreement
12/34/56
EX-10.4
from 10-Q ~5 pages First Amendment to Loan and Security Agreement
12/34/56
EX-10.3
from 8-K 9 pages Second Amendment to Loan Agreement
12/34/56
EX-10.1
from 8-K 57 pages Loan and Security Agreement
12/34/56
EX-10.4
from 8-K/A 14 pages Amendment to Loan Agreement
12/34/56
EX-10.1
from 8-K/A 88 pages Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 46 pages Loan Agreement Dated as of July 25, 2012 Between Navidea Biopharmaceuticals, Inc., as Borrower and Platinum-Montaur Life Sciences LLC, as Lender
12/34/56
EX-10.1
from 8-K 50 pages Loan and Security Agreement
12/34/56